FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054274831> ?p ?o ?g. }

• W2054274831 endingPage "363" @default.
• W2054274831 startingPage "357" @default.
• W2054274831 abstract "Combinations of a muscarinic receptor antagonist (MA) and a β(2)-adrenoceptor agonist (BA) improve bronchodilation in COPD patients to a greater extent than drugs with either mechanism alone. Here, using an in vivo model of bronchoprotection in guinea pigs, we characterize a single agent with dual-acting MA and BA activity, THRX-200495 (MABA). THRX-200495 was compared to a fixed-dose combination of a short-acting muscarinic receptor antagonist (SAMA) and a β(2)-adrenoceptor agonist (SABA). The SAMA/SABA combination consisted of a 1:5.7 ratio of ipratropium and albuterol (the components of Combivent®). Conscious guinea pigs received aqueous nebulized solutions of vehicle or test compound by aerosol exposure. Bronchoprotective potency was estimated in anesthetized, tracheotomized and ventilated guinea pigs at predetermined time points after aerosol exposure by measuring changes in ventilation pressure. The individual (MA, BA) and composite (MABA) pharmacologies were assessed by determining protection against bronchoconstrictor responses induced by methacholine in the presence of propranolol (for MA activity), histamine (for BA activity) or methacholine (MABA activity). Bronchoprotection was calculated as percent inhibition of methacholine or histamine response relative to the vehicle group. THRX-200495 exhibited matched MA (ID(50) = 11.4 μg/mL) and BA (ID(50) = 11.2 μg/mL) potency and potent dual pharmacology (MABA ID(50) = 3.5 μg/mL) that persisted for over 24 h. The combination of ipratropium/albuterol exhibited bronchoprotective activity that was 2.6-fold more potent as a BA (ID(50) = 5.7 μg/mL) than as an MA (ID(50) = 14.6 μg/mL) at 0.5 h post-dose and 37-fold more potent as an MA (ID(50) = 4.3 μg/mL) than a BA (ID(50) = 159 μg/mL) at 1.5 h post aerosol exposure. Under MABA pharmacological conditions, ipratropium/albuterol produced potent bronchoprotective activity (ID(50) = 2.0/11.4 μg/mL) and an apparent additive effect of the two pharmacologies. In conclusion, a dual-acting prototypical MABA, THRX-200495, demonstrated potent, balanced and long-lasting bronchodilation in a guinea pig model of bronchoprotection that was greater than either the MA or BA mechanisms alone." @default.
• W2054274831 created "2016-06-24" @default.
• W2054274831 creator A5021997634 @default.
• W2054274831 creator A5033485714 @default.
• W2054274831 creator A5042845839 @default.
• W2054274831 creator A5061257605 @default.
• W2054274831 creator A5064230455 @default.
• W2054274831 creator A5064325626 @default.
• W2054274831 creator A5068994903 @default.
• W2054274831 date "2012-10-01" @default.
• W2054274831 modified "2023-09-27" @default.
• W2054274831 title "Preclinical efficacy of THRX-200495, a dual pharmacology muscarinic receptor antagonist and β2-adrenoceptor agonist (MABA)" @default.
• W2054274831 cites W1505809298 @default.
• W2054274831 cites W1558590611 @default.
• W2054274831 cites W181810780 @default.
• W2054274831 cites W1976861853 @default.
• W2054274831 cites W1980789906 @default.
• W2054274831 cites W1982494955 @default.
• W2054274831 cites W1992410603 @default.
• W2054274831 cites W1998547311 @default.
• W2054274831 cites W2002609353 @default.
• W2054274831 cites W2013327701 @default.
• W2054274831 cites W2019031130 @default.
• W2054274831 cites W2019902477 @default.
• W2054274831 cites W2027178145 @default.
• W2054274831 cites W2045082657 @default.
• W2054274831 cites W2054504214 @default.
• W2054274831 cites W2069562921 @default.
• W2054274831 cites W2072148951 @default.
• W2054274831 cites W2073776604 @default.
• W2054274831 cites W2074631079 @default.
• W2054274831 cites W2083414123 @default.
• W2054274831 cites W2093928879 @default.
• W2054274831 cites W2094495786 @default.
• W2054274831 cites W2095416857 @default.
• W2054274831 cites W2096986362 @default.
• W2054274831 cites W2101168928 @default.
• W2054274831 cites W2101932319 @default.
• W2054274831 cites W2104356664 @default.
• W2054274831 cites W2104636056 @default.
• W2054274831 cites W2113713722 @default.
• W2054274831 cites W2117547745 @default.
• W2054274831 cites W2118954823 @default.
• W2054274831 cites W2126446114 @default.
• W2054274831 cites W2130890836 @default.
• W2054274831 cites W2140730458 @default.
• W2054274831 cites W2142724633 @default.
• W2054274831 cites W2153810843 @default.
• W2054274831 cites W2163053179 @default.
• W2054274831 cites W2164405525 @default.
• W2054274831 cites W2167700568 @default.
• W2054274831 cites W2183439328 @default.
• W2054274831 cites W2318270212 @default.
• W2054274831 cites W2343087379 @default.
• W2054274831 doi "https://doi.org/10.1016/j.pupt.2012.06.007" @default.
• W2054274831 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22766316" @default.
• W2054274831 hasPublicationYear "2012" @default.
• W2054274831 type Work @default.
• W2054274831 sameAs 2054274831 @default.
• W2054274831 citedByCount "13" @default.
• W2054274831 countsByYear W20542748312013 @default.
• W2054274831 countsByYear W20542748312014 @default.
• W2054274831 countsByYear W20542748312015 @default.
• W2054274831 countsByYear W20542748312016 @default.
• W2054274831 countsByYear W20542748312017 @default.
• W2054274831 countsByYear W20542748312020 @default.
• W2054274831 countsByYear W20542748312021 @default.
• W2054274831 crossrefType "journal-article" @default.
• W2054274831 hasAuthorship W2054274831A5021997634 @default.
• W2054274831 hasAuthorship W2054274831A5033485714 @default.
• W2054274831 hasAuthorship W2054274831A5042845839 @default.
• W2054274831 hasAuthorship W2054274831A5061257605 @default.
• W2054274831 hasAuthorship W2054274831A5064230455 @default.
• W2054274831 hasAuthorship W2054274831A5064325626 @default.
• W2054274831 hasAuthorship W2054274831A5068994903 @default.
• W2054274831 hasConcept C1122143 @default.
• W2054274831 hasConcept C126322002 @default.
• W2054274831 hasConcept C170493617 @default.
• W2054274831 hasConcept C185592680 @default.
• W2054274831 hasConcept C202751555 @default.
• W2054274831 hasConcept C2776178081 @default.
• W2054274831 hasConcept C2776723954 @default.
• W2054274831 hasConcept C2776885963 @default.
• W2054274831 hasConcept C2777714996 @default.
• W2054274831 hasConcept C2778938600 @default.
• W2054274831 hasConcept C2781260171 @default.
• W2054274831 hasConcept C33789571 @default.
• W2054274831 hasConcept C55493867 @default.
• W2054274831 hasConcept C57992300 @default.
• W2054274831 hasConcept C71924100 @default.
• W2054274831 hasConcept C98274493 @default.
• W2054274831 hasConceptScore W2054274831C1122143 @default.
• W2054274831 hasConceptScore W2054274831C126322002 @default.
• W2054274831 hasConceptScore W2054274831C170493617 @default.
• W2054274831 hasConceptScore W2054274831C185592680 @default.
• W2054274831 hasConceptScore W2054274831C202751555 @default.
• W2054274831 hasConceptScore W2054274831C2776178081 @default.
• W2054274831 hasConceptScore W2054274831C2776723954 @default.

• next